BOA-GARNET

Feasibility of Hemodialysis with GARNET™ In Chronic Hemodialysis Patients with a Bloodstream Infection (BOA-GARNET)

This is a prospective, multi-center, single arm study. Each subject will receive two (2) sessions of hemodialysis with the GARNET™ device, each of 3–4-hour duration at a minimum blood flow rate of 250 mL/min (with a maximum of 400 mL/min). The objective is to evaluate the feasibility of performing combined hemodialysis with the GARNET™ device in chronic hemodialysis patients with a blood stream infection (BSI), and measure clinical performance and safety endpoints